Gene: UBE2G1
Official Full Name: ubiquitin conjugating enzyme E2 G1provided by HGNC
Gene Summary: The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family and catalyzes the covalent attachment of ubiquitin to other proteins. The protein may be involved in degradation of muscle-specific proteins. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03718 | UBE2G1 Knockout cell line (HeLa) | Human | UBE2G1 | 1:3~1:6 | Negative | Online Inquiry |
KO03719 | UBE2G1 Knockout cell line (HCT 116) | Human | UBE2G1 | 1:2~1:4 | Negative | Online Inquiry |
KO03720 | UBE2G1 Knockout cell line (HEK293) | Human | UBE2G1 | 1:3~1:6 | Negative | Online Inquiry |
KO03721 | UBE2G1 Knockout cell line (A549) | Human | UBE2G1 | 1:3~1:4 | Negative | Online Inquiry |
UBE2G1 gene knockout cell lines are genetically modified cellular models that feature targeted deletions of the UBE2G1 gene, which encodes an E2 ubiquitin-conjugating enzyme involved in the ubiquitin-proteasome system. These cell lines are designed to facilitate research into the roles of UBE2G1 in various biological processes, including protein degradation, cell cycle regulation, and DNA repair.
The primary function of UBE2G1 is to covalently attach ubiquitin molecules to substrates, thus marking them for degradation by the proteasome or altering their cellular localization and function. The knockout of this gene allows researchers to investigate the resultant phenotypic changes and the impact on cellular homeostasis, signaling pathways, and responses to stressors. This mechanistic understanding is critical for elucidating the gene's role in disease contexts such as cancer and neurodegenerative disorders, where protein accumulation and misfolding play significant roles.
Scientifically, UBE2G1 gene knockout cell lines hold substantial value in both research and clinical applications. In academia, these models can be utilized to explore fundamental biological questions related to ubiquitin-mediated proteolysis. Clinically, the insights gained from studies using these cell lines may inform the development of therapeutic strategies targeting UBE2G1 and related pathways, ultimately enhancing treatment options for diseases characterized by dysregulated protein turnover.
One of the standout advantages of our UBE2G1 gene knockout cell lines is their precision and reliability in modeling UBE2G1 function, compared to conventional methods like RNA interference, which can produce off-target effects. These knockout lines enable stringent validation of hypotheses regarding UBE2G1 roles, providing a clean genetic background that enhances experimental reproducibility.
For researchers and clinicians aiming to unlock the complexities of cellular processes and disease mechanisms, UBE2G1 gene knockout cell lines represent a powerful tool that can generate impactful scientific insights. Our company is committed to providing high-quality biological products, and our expertise in delivering precisely-engineered cellular models ensures that you have access to the most reliable tools for your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.